Síntesis total y análisis inicial estructura-función de los potentes inhibidores de la V-ATPasa salicilihalamida A y compuestos relacionados
Video Experimental Relacionado
Updated: Jul 8, 2026
07:33
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
Published on: October 15, 2018
Yusheng Wu1, Xibin Liao, Ruifang Wang
1Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9038, USA.
Journal of the American Chemical Society
|March 28, 2002
Resumen
La salicilihalamida A, un producto natural, es un potente inhibidor de la (H+) -ATPasa vacuolar. Sus estudios de síntesis total y estructura-función revelan potencial para el tratamiento de la osteoporosis y el cáncer.
Área de la Ciencia:
- Productos naturales Química Productos naturales Química
- Síntesis orgánica La síntesis orgánica.
- La bioquímica es la bioquímica.
Sus antecedentes:
- La salicilihalamida A es un producto natural de salicilato macrocíclico.
- Muestra una citotoxicidad única e inhibe la vacuolar (H+) -ATPasa de mamíferos.
- Comprender su mecanismo y desarrollar análogos es crucial.
Objetivo del estudio:
- Para lograr la síntesis total de ambos enantiómeros de la salicilihalamida A.
- Para revisar la configuración absoluta del producto natural.
- Para llevar a cabo estudios estructura-función con análogos sintéticos.
Principales métodos:
- Una estrategia sintética eficiente que involucra la metátesis de olefinas de cierre de anillo E-selectivo.
- Elaboración estereocontrolada de un intermediario de isocyanato de E-alquenilo.
- Adición nucleofílica al isocyanato para obtener salicilihalamida A y sus congéneres.
Principales resultados:
- El éxito de la síntesis total de ambos enantiómeros de salicilihalamida A.
- Demostración de la salicilihalamida A como un potente inhibidor de la V-ATPasa purificada.
- Identificación de potentes derivados modificados de la cadena lateral, incluidos los dímeros.
Conclusiones:
- La estrategia sintética permite estudios exhaustivos de la salicilihalamida A.
- La salicylihalamida A es un potente inhibidor de la V-ATPasa.
- Los análogos son prometedores para el desarrollo de pistas terapéuticas para la osteoporosis y el cáncer.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:18ATP Synthase: Structure
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
01:30ATP Driven Pumps III: V-type Pumps
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...